Absidia corymbifera infection

Also Known As:

Lichtheimia corymbifera infection; Mucor corymbifer infection; Mycocladus corymbifer infection

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

1.	End Stage Liver Disease
2.	Pulmonary Aspergillosis
3.	Osteosarcoma (Osteogenic Sarcoma)
4.	Mucormycosis
5.	Non-Hodgkin Lymphoma (Lymphosarcoma)

1.	Balter, Rita: 1 article (01/2020)
2.	Bonetti, Elisa: 1 article (01/2020)
3.	Brazzarola, Paolo: 1 article (01/2020)
4.	Bruno, Costanza: 1 article (01/2020)
5.	Cesaro, Simone: 1 article (01/2020)
6.	Chinello, Matteo: 1 article (01/2020)
7.	De Bortoli, Massimiliano: 1 article (01/2020)
8.	Lo Cascio, Giuliana: 1 article (01/2020)
9.	Mauro, Margherita: 1 article (01/2020)
10.	Vitale, Virginia: 1 article (01/2020)

Drugs and Important Biological Agents (IBA) related to Absidia corymbifera infection:

1.	Amphotericin B (Amphotericin)FDA LinkGeneric 05/01/2004 - "We report successful treatment of a case of Absidia corymbifera infection with the combination of amphotericin B and surgical debridement of the affected area." 01/01/2003 - "An unusual case of a primary cutaneous Absidia corymbifera infection in a premature twin successfully treated with low doses of intravenous amphotericin B and topical natamycin is described. " 10/01/2001 - "The activities of amphotericin B and itraconazole were studied in a temporarily neutropenic murine model of disseminated Absidia corymbifera infection, caused by two different strains. " 10/01/2001 - "Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole."
2.	Itraconazole (Sporanox)FDA LinkGeneric 10/01/2001 - "The activities of amphotericin B and itraconazole were studied in a temporarily neutropenic murine model of disseminated Absidia corymbifera infection, caused by two different strains. " 10/01/2001 - "Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole."
3.	Natamycin (Pimaricin)FDA Link 01/01/2003 - "An unusual case of a primary cutaneous Absidia corymbifera infection in a premature twin successfully treated with low doses of intravenous amphotericin B and topical natamycin is described. "

1.	Therapeutics 03/01/2010 - "Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma." 01/01/2020 - "We describe a case of of Lichtheimia corymbifera infection in a 15-year-old child with B-cell-Non-Hodgkin Lymphoma (B-NHL) involving lung, kidney and thyroid that initially was diagnosed as probable aspergillosis delaying the effective therapy for mucormycosis. "
2.	Liver Transplantation 05/01/1997 - "Staphylococcus aureus bacteraemia, Absidia corymbifera infection and probable pulmonary aspergillosis in a recipient of orthotopic liver transplantation for end stage liver disease secondary to hepatitis C."
3.	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/01/2000 - "Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation."
4.	Debridement 05/01/2004 - "We report successful treatment of a case of Absidia corymbifera infection with the combination of amphotericin B and surgical debridement of the affected area."
5.	Bandages (Bandage) 09/01/2005 - "An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit."